Comparing the current results to its competitors, Progyny Inc reported Revenue increase in the 2 quarter 2026 by 5.58 % year on year. The sales growth was above Progyny Inc 's competitors' average revenue growth of 1.8 %, achieved in the same quarter.
Progyny Inc 's Comment on Competition and Industry Peers
The company positions itself as a provider of employer-sponsored women's health and family building solutions, emphasizing comprehensive benefit offerings, outcomes, access, member experience, provider networks, data reporting, and integrated pharmacy solutions. Its primary competitors include health insurance companies that manage fertility benefits within their health plan administration. Additional competitors consist of specialty fertility-focused solutions affiliated with health insurers that offer services such as case management and educational support, as well as venture capital or private equity-backed firms specializing in maternity, reproductive health services, or fertility-specific benefits.
With revenue growth of 5.58 % within Overall company, Progyny Inc achieved improvement in market share, within Overall company to approximately 24.71 %. << More on PGNY Market Share.
*Market share is calculated based on total revenue.
June 10, 2025
In a groundbreaking partnership, Progyny Inc. has become the first women’s health and family building solution to join Amazon s Health Benefits Connector Program. This collaboration promises to empower Amazon customers eligible for Progyny services by facilitating their access to vital fertility, family building, and menopause benefits. The initiative is not just about offering health benefits; it reflects a wider recognition of the need for specialized women’s health services in the corporate benefits space.As societal norms regarding family planning evolve, so do the corporate benefits that support them. The introduction of Progyny into Amazon s offerings allows employees to discover comprehensive heal...
April 17, 2024
In a remarkable show of support, Progyny and Fertility Matters Canada, two leading organizations in the field of fertility care, have come together to recognize and advocate for Canadian Fertility Awareness Week. This joint effort aims to raise awareness about the challenges faced by millions of individuals and couples in need of family building care across the country. As they host an event with prominent providers, employers, and fertility advocates, the organizations hope to pave the way for expanded access to essential reproductive services.Canadians have long struggled with limited access to fertility treatments and family-building care, leading to immense emotional, physical, and financial distress for...
The Cooper Companies Inc is a global medical device firm focused on manufacturing and distributing contact lenses and womens healthcare products. Its business model emphasizes innovation, strong distribution, strategic acquisitions, and partnerships to enhance market presence, targeting the specific needs of customers in eye care and womens health. Through research and development, they aim to improve customer lives while maximizing shareholder value.
Inmed Pharmaceuticals Inc is a biopharmaceutical company that focuses on the development of cannabinoid-based therapies for various diseases. The company's business model revolves around conducting research and development to identify novel drug candidates, conducting pre-clinical and clinical trials to test the safety and efficacy of these candidates, and seeking partnerships or collaborations with other pharmaceutical companies for the further development and commercialization of successful therapies. By leveraging advancements in cannabinoid science, Inmed Pharmaceuticals aims to provide innovative medical treatments for unmet medical needs.
Rani Therapeutics Holdings Inc utilizes a novel approach in developing therapeutics by delivering large molecules orally, avoiding the need for injections.
Sources:
Progyny Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Progyny Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
